3D Systems Corporation
Key statistics
from XBRL data in SEC filingsAI briefing
from the latest 10-K, 10-Q and 8-K events3D Systems is an additive manufacturing technology company providing 3D printers, materials, software, and services across healthcare and industrial verticals.
What they do
3D Systems provides comprehensive 3D printing and digital manufacturing solutions, including printers for plastics and metals, proprietary materials, software, and services. It operates through two reportable segments: Healthcare Solutions (dental, medical devices, personalized health services, regenerative medicine) and Industrial Solutions (aerospace, defense, transportation, general manufacturing). The company sells globally across the Americas, EMEA, and APAC.
Revenue drivers
- Healthcare Solutions — Largest segment, with Q2 2026 revenue up 6.8% year-over-year, driven by over 20% growth in Med Tech and 3% growth in Dental.
- Industrial Solutions — Revenue declined 6.7% year-over-year, but grew 2.4% sequentially, with over 20% growth in Aerospace Defense and Data Center Infrastructure.
- Product sales (printers and materials) — Double-digit growth in both metal and polymer hardware printer systems in Q2 2026; materials are largely proprietary and drive recurring revenue.
- Software and services — Includes maintenance contracts, software maintenance, SaaS subscriptions, and healthcare services; part of the recurring revenue stream.
Recent performance
For Q2 2026 (period ended June 30, 2026), revenue was $94.6 million, down 0.3% year-over-year, but up 1.4% excluding divestitures. Net loss was $(12.9) million, while Adjusted EBITDA improved to a loss of $(0.8) million; for the first half of 2026, net loss was $(17.3) million and Adjusted EBITDA was positive $1.3 million. Full-year 2025 revenue was $386.9 million with net income of $29.9 million, including a $125.7 million pre-tax gain from the sale of Geomagic. Operating cash flow was negative $87.8 million in 2025. As of June 30, 2026, the company had cash of $128.0 million and long-term debt of $87.2 million.
Strategy
Management is focused on accelerating additive manufacturing adoption in four priority markets: Med Tech, Dental, Aerospace Defense, and Data Center Infrastructure, all of which grew over 20% in the first half of 2026. The company is investing in R&D to launch new products and expand its installed base, while also expanding parts manufacturing capabilities. A 2025 Restructuring Plan was authorized to streamline infrastructure and processes, with $8.5 million in severance costs incurred in 2025; management expects no significant additional restructuring charges in 2026. Divestitures of Geomagic and 3DXpert/Oqton were completed to focus on core operations.
Risks
- Macroeconomic headwinds — Elevated interest rates and credit tightening may reduce customer financing availability and capital spending, adversely affecting demand.
- Revenue concentration — The company faces concentration of revenue and credit risk from its largest customer, which could amplify the impact of a loss.
- Debt and liquidity — The company has convertible notes due 2026 and 2030 and must maintain ability to service debt and fund conversions; negative operating cash flow persists.
- Internal control material weaknesses — The company must remediate material weaknesses in internal controls over financial reporting, which could affect reliability of financial statements.
Outlook
Management is optimistic that as capital investment strengthens, the company is well positioned to benefit from expansion in global manufacturing capacity. They expect continued core revenue growth adjusted for divestitures, and focus on margin expansion and profitability. The global economic environment remains uncertain, and the company will continue to monitor supply chain, liquidity, and customer order trends.